Revvity (RVTY) Asset Writedowns and Impairment (2013 - 2023)
Revvity (RVTY) posted Asset Writedowns and Impairment of -$3.9 million for Q1 2023, down 148.73% quarter-over-quarter from $7.9 million in Q1 2021.
Revvity (RVTY) Asset Writedowns and Impairment (2013 - 2023) Analysis & Trends
Revvity (RVTY) has reported Asset Writedowns and Impairment for 3 consecutive years, with -$3.9 million the latest figure, recorded in Q1 2023.
- Asset Writedowns and Impairment for Q1 2023 came in at -$3.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $4.3 million (changed N/A YoY), and the FY2025 annual result was $4.8 million, down 79.03% from the prior year.
- Asset Writedowns and Impairment was -$3.9 million for Q1 2023 at Revvity, down from $7.9 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $7.9 million in Q1 2021 and troughed at -$3.9 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Revvity | 12.62 Bn | 11.76 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 1, 2023 | -3.87 Mn |
| Jan 1, 2023 | -3.87 Mn |
| Jan 3, 2021 | 7.94 Mn |
| Jan 3, 2021 | 7.94 Mn |
| Dec 29, 2013 | 200,000.00 |
| Dec 29, 2013 | 200,000.00 |